One in nine may get delayed large local reaction after Moderna vaccine
Jun 10, 2022
A higher risk was seen among women and among individuals aged 30 to 69 years.
Moderna vaccine may shield more against breakthrough infections than Pfizer: study
Aug 12, 2021
The Mayo Clinic researchers found that in Minnesota last month, the Moderna vaccine was 76% effective at preventing a breakthrough infection, whereas the Pfizer vaccine was only 42% effective.
CDC, AMA urge Americans to make sure they are vaccinated against measles
Mar 19, 2024
Cases are rising in the United States and globally due to pockets of unvaccinated people.
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
In effort to boost COVID-19 vaccinations to homebound, CMS to pay $35 more per dose
By
Diane Eastabrook
Jun 09, 2021
The Centers for Medicare and Medicaid Services (CMS) announced Wednesday an additional payment for administering in-home COVID-19 vaccinations to Medicare beneficiaries having difficulty leaving their...
Camaraderie, coaching, cash, car: One provider’s quest to increase COVID vaccination among staff
By
Kimberly Bonvissuto
Jul 06, 2021
Vaccinated workers for a Vero Beach, FL-based senior living operator stand to win a piece of $100,000 in cash prizes and a 2021 Nissan Versa in a grand prize drawing this week. But the company’s...
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
Adverse events associated with BNT162b2 vaccination ID’d
Aug 27, 2021
Vaccination with the Pfizer–BioNTech mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with an increased risk for myocarditis and lymphadenopathy, according...
Adenoviral-based COVID-19 vaccines may up short-term CV risk
Aug 23, 2022
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
Moderna CEO says fourth COVID-19 dose may be needed next fall
Jan 07, 2022
Governments, including the United Kingdom and South Korea, already are ordering the doses in preparation.